Physical ActivityQuality of LifeFunctional Fitness
Investigational drug(s) / intervention(s)
The group-based mat exercise training on experimental group.The control group
The group-based mat exercise training on experimental group.: The training program is divided into two phases: the first phase focuses on fundamental movements, whereas the second phase introduces more advanced exercises. With progress, additional exercise equipment is incorporated, along with increased sets, duration, movement variations, and training intensity. Training sessions (10-week duration) can be conducted in a simple, progressive manner or a game-competitive format.The control group maintained their usual daily activities.
The control group: The control group maintained their usual daily activities.
Study summary
In this study, investigators recruited older adults aged 60 to 80 years and utilized a parallel experimental design. A total of 32 participants were randomly assigned to either the experimental or control group. The intervention consisted of a 70-min-long exercise game-based mat training session conducted twice weekly for 10 consecutive weeks. Each session included a 10-min warm-up, approximately 45 min of primary training, and a 15-min cool-down and stretching routine. Participants completed the International Physical Activity Questionnaire (IPAQ) and the World Health Organization Quality of Life questionnaire (WHOQOL, Taiwanese Version) before and after the intervention. Additionally, the functional fitness assessment were conducted.
Eligibility
Sex
ALL
Min age
60 Years
Max age
80 Years
Healthy volunteers
Accepted
Inclusion Criteria:
(i) Elderly individuals (aged 60-80) who have not experienced any muscle or skeletal injuries in the past month and are able to participate in training normally.
(ii) Completion of the Physical Activity Readiness Questionnaire and meeting the conditions for initiating moderate-intensity exercise intervention.
(iii) Ability to comply with the exercise frequency required by this study and travel to and from the training site independently.
Exclusion Criteria:
(i) individuals with severe musculoskeletal disorders, (ii) individuals deemed unsuitable for exercise training based on a Physical Activity Readiness Questionnaire evaluation or psychiatric disorders, and (iii) individuals under medications that may influence study outcomes.
Primary outcome measure(s)
International Physical Activity Questionnaire — The evaluation was conducted at baseline and the 11th week time points. The questionnaire was applied to evaluate the physical activities. The duration of activity will be converted into metabolic equivalents (METs), with higher MET values indicating a greater level of physical activity.
World Health Organization Quality of Life questionnaire — The evaluation was conducted at baseline and the 11th week time points. The questionnaire was applied to evaluate the quality of life. A self-assessment will be conducted for different dimensions of quality of life, with higher values indicating greater satisfaction in that particular dimension.
Senior fitness — The evaluation was conducted at baseline and the 11th week time points. The regular physical fitness was evaluated by indicated senior fitness test. This fitness test measures the number of repetitions performed within a specific time frame, with higher values indicating better fitness. However, for dynamic balance, a shorter time indicates better performance.
Functional fitness — The evaluation was conducted at baseline and 11th week time points. The functional fitness was evaluated by sport technology-based AFAscan fitness assessment. This fitness test measures the number of repetitions performed within a specific time frame, with higher values indicating better fitness.
Trial sites (1)
Facility
City
Region
Status
National Taipei University of Nursing and Health Sciences
Taipei
Taiwan
More National Taipei University of Nursing and Health Sciences trials in Taiwan
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.